Changjun He

1.1k citations
17 papers · 819 indexed · h-index 12
Topics
MicroRNA in disease regulation (5 papers)Cancer-related molecular mechanisms research (5 papers)Cancer, Hypoxia, and Metabolism (3 papers)
Journals
SHILAP Revista de lepidopterologíaEuropean Journal of PharmacologyCell Death and Disease

In The Last Decade

Changjun He

17 papers receiving 814 citations

Peers

Changjun He
Comparison fields: 5 of 73
  • Molecular Biology 478
  • Cancer Research 452
  • Oncology 167
  • Epidemiology 132
  • Hepatology 109
Replace Qingguang Liu with:
Qingguang Liu China
Zongzhen Xu China
Caner Ercan Switzerland
Angélique Gougèlet France
Arihiro Aihara Japan
Zeribe C. Nwosu United States
So Mee Kwon South Korea
Robin Kit‐Ho Lai Hong Kong
Jin He China
Larry Lai Wei Hong Kong
Changjun He relative to Qingguang Liu China Qingguang Liu's profile →
Citations per field
00.5×1.5×
Qingguang Liu · 1×
Citations per year

Countries citing papers authored by Changjun He

Since Specialization
Citations

This map shows the geographic impact of Changjun He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changjun He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changjun He more than expected).

Fields of papers citing papers by Changjun He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changjun He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changjun He. The network helps show where Changjun He may publish in the future.

Co-authorship network of co-authors of Changjun He

This figure shows the co-authorship network connecting the top 25 collaborators of Changjun He. A scholar is included among the top collaborators of Changjun He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changjun He. Changjun He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 2
2 5
3 21
4 5
5 36
6 7
7 162
8 9
9 16
10 22
11 191
12 126
13 38
14 32
15 54
16 52
17 41

About Changjun He

Changjun He is a scholar working on Cancer Research, Hepatology and Developmental Neuroscience, having authored 17 papers that have together received 819 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Hypoxia, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (452 citations), Hepatology (109 citations) and Molecular Biology (478 citations). Changjun He has collaborated with scholars based in China, New Zealand and Australia. Frequent co-authors include Xueying Sun, Hongchi Jiang, Xian Jiang, Bo Zhai, Xuesong Dong, Haiquan Qiao, Gang Tan, Shidong Xu, Lixin Ma and De‐Li Dong. Their work appears in journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026